BSE filing, BSE: 514260. Summary written from the filing by ALFA Finder's alert engine.
Surbhi Industries Ltd: key numbers
- Share price
- ₹75.04
- Market cap
- ₹25.79 Cr
- Revenue (annual)
- ₹31.54 Cr
- Net profit (annual)
- ₹1.99 Cr
- P/E (TTM)
- 13.8×Sector 49.0×
- Promoter holding
- 71.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Surbhi Industries Ltd
All →Surbhi Industries Other Announcement
Surbhi Industries submitted the quarterly compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Surbhi Industries Other Announcement
Surbhi Industries Ltd re-appointed M/S Ghael Choksi & Company as statutory auditors for a five-year term, as approved during the 34th Annual General Meeting.
Surbhi Industries Management Change
Surbhi Industries Limited announced the re-appointment of Mr. Ravjibhai Parbatbhai Patel as Managing Director and Mr. Bipinbhai Jasmatbhai Patel as Whole-Time Director, approved by shareholders.
Surbhi Industries Annual General Meeting
Surbhi Industries Limited held its 34th Annual General Meeting on September 29, 2026. Members transacted routine business including adopting financial statements and re-appointing directors and statutory auditors.
Surbhi Industries Other Announcement
Surbhi Industries Limited announced the board-approved appointment of M/s Ghael Choksi & Company as the new Statutory Auditor for a five-year term, subject to shareholder approval.
Surbhi Industries Board Meeting Outcome
Surbhi Industries' board approved a Whole-time Director's re-appointment, appointed a new statutory auditor, and scheduled the 34th Annual General Meeting for September 29, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.